GGrantIndex
Sort

39,280 grants matching leukemia

Project 2 - IMiD Resistance in Patients and Humanized Mice with Multiple Myeloma

$391,500
Peter Leif Bergsagel · Mayo Clinic Arizona · U54 · FY2019 · CA

Molecular Determinants of Decitabine Response

$391,498
Timothy J Ley · Washington University · P50 · FY2017 · CA

Molecular and Cellular Characterization of Myeloproliferative Disease

$391,483
Kathleen Miho Sakamoto · University Of California Los Angeles · R01 · FY2008 · HL

Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas

$391,435
Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2020 · CA

Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas

$391,435
Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2021 · CA

Leukemia Immunotherapy After Allogeneic Transplant

$391,430
University Of Rochester · R01 · FY2005 · CA

THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL

$391,427
Timothy J Ley · Washington University · R01 · FY2012 · CA

PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia

$391,413
Kira Gritsman · Albert Einstein College Of Medicine · R01 · FY2020 · CA

MOLECULAR MECHANISMS OF NUCLEIC ACID DAMAGE BY ENEDIYNES

$391,372
Harvard University (Medical School) · R01 · FY2002 · GM

The chromatin remodeler Mi2 in T cell development

$391,362
Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2007 · AI

Biochemistry of Leukemia Virus Core Binding Factor

$391,315
Dartmouth College · R01 · FY2004 · CA

DEVELOPMENT & EVALUATION OF PRACTICABLE APPROACHES FOR GENERATION OF CYTOTOXIC &

$391,307
Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA

Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases

$391,301
Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2023 · GM

Genetic and molecular mechanisms of replication of araC damaged DNA

$391,297
Satya Prakash · University Of Texas Med Br Galveston · R01 · FY2019 · CA

Structure and Mechanism of Epigenetic Gene Silencing

$391,250
Vignesh Kasinath · University Of Colorado · R35 · FY2024 · GM

Structure and Mechanism of Epigenetic Gene Silencing

$391,250
Vignesh Kasinath · University Of Colorado · R35 · FY2025 · GM

The role of SERINC5 in HIV-1 replication

$391,250
Yong-Hui Zheng · Michigan State University · R01 · FY2020 · AI

Functional genetics of human innate immunity in the bimodal gamma delta T cell response to Epstein-Barr Virus and in education of NK cells and their re-education to respond to autologous cells

$391,250
Peter R Parham · Stanford University · R01 · FY2023 · AI

Functional genetics of human innate immunity in the bimodal gamma delta T cell response to Epstein-Barr Virus and in education of NK cells and their re-education to respond to autologous cells

$391,250
Peter R Parham · Stanford University · R01 · FY2022 · AI

Functional genetics of human innate immunity in the bimodal gamma delta T cell response to Epstein-Barr Virus and in education of NK cells and their re-education to respond to autologous cells

$391,250
Peter R Parham · Stanford University · R01 · FY2021 · AI

Functional genetics of human innate immunity in the bimodal gamma delta T cell response to Epstein-Barr Virus and in education of NK cells and their re-education to respond to autologous cells

$391,250
Peter R Parham · Stanford University · R01 · FY2020 · AI

The role of SERINC5 in HIV-1 replication

$391,250
Yong-Hui Zheng · Michigan State University · R01 · FY2019 · AI

Functional genetics of human innate immunity in the bimodal gamma delta T cell response to Epstein-Barr Virus and in education of NK cells and their re-education to respond to autologous cells

$391,250
Peter R Parham · Stanford University · R01 · FY2019 · AI

CANCER AND LEUKEMIA GROUP B

$391,239
Dana-Farber Cancer Institute · U10 · FY2001 · CA

PHASE I TRIALS OF ANTICANCER AGENTS

$391,225
University Of Maryland Baltimore · U01 · FY2001 · CA